Genetic study for ovarian cancer treatments
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at genetic changes in ovarian cancer to find possible targeted treatments. It may help you if you have certain types of ovarian cancer and are seeking more personalized care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older
- You have been diagnosed with epithelial ovarian cancer (common types like high-grade serous, endometrioid, or clear cell)
- You agree to take part and sign a consent form, or your past tissue sample can be used with approval
- You do not have low-grade or non-epithelial ovarian tumors
- Your medical and test information is available for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.
This study looks at how medical images relate to genetic patterns in high-grade serous ovarian cancer. It may help find better ways to diagnose and treat this specific type of ovarian cancer.
This study looks at certain “DNA repair traits” (called homologous recombination phenotype) in people with epithelial ovarian cancer. Results may help researchers better understand who responds to platinum chemotherapy, which is commonly used for this cancer.
This study aims to use your tumor and blood samples to find the best treatment for your ovarian cancer. It may help tailor your care based on your unique cancer biology.
This study tests genetic (DNA) information to help doctors identify ovarian or uterine (endometrial) cancer sooner. You may be asked to do this around the time of planned surgery, when tissue is removed and can be checked for genetic clues.
This trial is creating a detailed registry of genetic changes found in ovarian tumors in Taiwan. It aims to better understand the disease by collecting tumor tissue and blood samples from patients with high-grade serous or clear cell ovarian, fallopian tube, or peritoneal cancer.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.